We [10, 11, 15] and others [46–49] have demonstrated that the nuclear-encoded COX4 isoforms are key regulatory subunits of mammalian CcO and could have a role in GBM resistance to therapy. The gene discussed is COX4I2; the disease is glioblastoma.